Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Efficacy of eHealth Technologies on Medication Adherence in Patients with Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
ABSTRACT
Background:
Suboptimal adherence to cardiac pharmacotherapy recommended by the guidelines after acute coronary syndrome (ACS) has been recognized and is associated with adverse outcomes like mortality. Several randomized controlled trials (RCTs) have shown that eHealth technologies are useful in reducing cardiovascular risk factors. However, little is known about the effect of eHealth interventions on medication adherence in patients following ACS.
Objective:
To examine the efficacy of the eHealth interventions on medication adherence to selected five cardioprotective medication classes in patients with ACS.
Methods:
A systematic literature search was conducted to identify RCTs that evaluated the effectiveness of eHealth technologies, including text messaging, smartphone applications, or web-based applications, to improve medication adherence in patients after ACS. A pooled meta-analysis was performed using a fixed effect Mantel-Haenszel model and assessed the medication adherence to the medications of statins, aspirin, P2Y12 inhibitors, angiotensin-convertase enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs), and β-blockers.
Results:
We identified five RCTs, applicable to 4100 participants (2093 intervention v 2007 control), for inclusion in the meta-analysis. In patients who recently had an ACS, compared to control group, the use of eHealth intervention was not associated with improved adherence to statins at different time points (risk difference [RD]: -0.00; 95% CI: -0.03 – 0.02 at 6-month and 0.00, -0.02 – 0.03 at 12-month), P2Y12 inhibitors (0.00, -0.03 – 0.03 and 0.00, -0.03 – 0.03), aspirin (0.00, -0.03 – 0.03 and 0.00, -0.03 – 0.04), ACEIs/ARBs (-0.01, -0.03 – 0.02 and -0.03, -0.06 – 0.01), and β-blockers (0.07, -0.12 – 0.27 and 0.02, -0.03 – 0.06). The intervention was also no associated with improved adherence irrespective of the adherence assessment method employed (self-report or objective).
Conclusions:
The limited available data suggest that eHealth interventions may play little role in improving adherence to cardioprotective medications in patients following ACS.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.